Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
Titel:
Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
Auteur:
Condorelli, R. Mosele, F. Verret, B. Bachelot, T. Bedard, P.L. Cortes, J. Hyman, D.M. Juric, D. Krop, I. Bieche, I. Saura, C. Sotiriou, C. Cardoso, F. Loibl, S. Andre, F. Turner, N.C.